Variation in human erythrocyte membrane unsaturated fatty acids

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 1, 2010, Pages 73-80

  Sepulveda, Jorge L ^a,b   Tanhehco, Yvette C ^a   Frey, Monica ^c   Guo, Lida ^c   Cropcho, Lorna J ^c,d   Gibson, K Michael ^c,d,e   Blair, Harry C ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^e MICHIGAN TECHNOLOGICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 OCTADECENOIC ACID; 5-OCTADECENOIC ACID; BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OCTADECADIENOIC ACID; PALMITIC ACID; STEARIC ACID DERIVATIVE; TROPONIN I; UNSATURATED FATTY ACID;

ADULT; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; ERYTHROCYTE MEMBRANE; HUMAN; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; ERYTHROCYTE MEMBRANE; FATTY ACIDS, UNSATURATED; HUMANS; MIDDLE AGED; PALMITIC ACID; RISK FACTORS; STEARIC ACIDS; TROPONIN I;

EID: 75149132815     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Martinelli N, Girelli D, Malerba G, et al. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am J Clin Nutr. 2008;88:941-949.
2. Lemaitre RN, Siscovick DS, Berry EM, Kark JD, Friedlander Y. Familial aggregation of red blood cell membrane fatty acid composition: the Kibbutzim Family Study. Metabolism. 2008;57:662-668.
3. Bersamin A, Luick BR, King IB, Stern JS, Zidenberg-Cherr S. Westernizing diets influence fat intake, red blood cell fatty acid composition, and health in remote Alaskan Native communities in the center for Alaska Native health study. J Am Diet Assoc. 2008;108:266-273.
4. Kabagambe EK, Tsai MY, Hopkins PN, et al. Erythrocyte fatty acid composition and the metabolic syndrome: a National Heart, Lung, and Blood Institute GOLDN study. Clin Chem. 2008;54:154-162.
5. Orton HD, Szabo NJ, Clare-Salzler M, Norris JM. Comparison between omega-3 and omega-6 polyunsaturated fatty acid intakes as assessed by a food frequency questionnaire and erythrocyte membrane fatty acid composition in young children. Eur J Clin Nutr. 2008;62:733-738.
6. Yoshida Y, Saito Y, Hayakawa M, et al. Levels of lipid peroxidation in human plasma and erythrocytes: comparison between fatty acids and cholesterol. Lipids. 2007;42:439-449.
7. Baylin A, Kim MK, Donovan-Palmer A, et al. Fasting whole blood as a biomarker of essential fatty acid intake in epidemiologic studies: comparison with adipose tissue and plasma. Am J Epidemiol. 2005;162:373-381.
8. Lee SS, Kim NJ, Sun K, et al. Association between arterial stiffness and the deformability of red blood cells (RBCs). Clin Hemorheol Microcirc. 2006;34:475-481.
9. Persson SU,Wohlfart G, Larsson H, Gustafson A. Correlations between fatty acid composition of the erythrocyte membrane and blood rheology data. Scand J Clin Lab Invest. 1996;56:183-190.
10. McFadyen M, Farquharson J, Cockburn F. Maternal and umbilical cord erythrocyte omega-3 and omega-6 fatty acids and haemorheology in singleton and twin pregnancies. Arch Dis Child Fetal Neonatal Ed. 2003;88:F134-F138.
11. Konig SA, Knolle J, Friedewald S, et al. Effects of valproic acid, carbamazepine, and phenobarbitone on the fatty acid composition of erythrocyte membranes in children. Epilepsia. 2003;44:708-711.
12. Suwalsky M, Mennickent S, Norris B, Villena F, Sotomayor CP. Effects of the antiepileptic drug carbamazepine on human erythrocytes. Toxicol In Vitro. 2006;20:1363-1369. (Pubitemid 44537663)
13. Koter M, Broncel M, Chojnowska-Jezierska J, Klikczynska K, Franiak I. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia. Eur J Clin Pharmacol. 2002;58:501-506.
14. Leaf A. Historical overview of n-3 fatty acids and coronary heart disease. Am J Clin Nutr. 2008;87:1978S-1980S.
15. Sun Q, Ma J, Campos H, Hankinson SE, Hu FB. Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr. 2007;86:74-81.
16. Nyalala JO, Wang J, Dang A, Faas FH, Smith WG. Hypertriglyceridemia and hypercholesterolemia: effects of drug treatment on fatty acid composition of plasma lipids and membranes. Prostaglandins Leukot Essent Fatty Acids. 2008; 78:271-280.
17. Denke MA. Dietary fats, fatty acids, and their effects on lipoproteins. Curr Atheroscler Rep. 2006;8:466-471.
18. Willett WC. Trans fatty acids and cardiovascular disease-epidemiological data. Atheroscler Suppl. 2006;7:5-8.
19. Micha R, Mozaffarian D. Trans fatty acids: effects on cardiometabolic health and implications for policy. Prostaglandins Leukot Essent Fatty Acids. 2008; 79:147-152.
20. Lopez-Garcia E, Schulze MB, Meigs JB, et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr. 2005;135:562-566.
21. Lemaitre RN, King IB, Raghunathan TE, et al. Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation. 2002;105:697-701.
22. Zhang D, YuW, Geisbrecht BV, Gould SJ, Sprecher H, Schulz H. Functional characterization of Delta3,Delta2-enoyl-CoA isomerases from rat liver. J Biol Chem. 2002;277:9127-9132.
23. Willett WC. The Mediterranean diet: science and practice. Public Health Nutr. 2006;9:105-110.
24. Dappen GM, Cumbo PE, Goodhue CT, et al. Dry film for the enzymic determination of total cholesterol in serum. Clin Chem. 1982;28:1159-1162.
25. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379-1388.
26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
27. Perichon R, Moser AB, Wallace WC, Cunningham SC, Roth GS, Moser HW. Peroxisomal disease cell lines with cellular plasmalogen deficiency have impaired muscarinic cholinergic signal transduction activity and amyloid precursor protein secretion. Biochem Biophys Res Commun. 1998;248:57-61.
28. Woo KL, Kim JL. New hydrolysis method for extremely small amount of lipids and capillary gas chromatographic analysis as n(O)-tert.- butyldimethylsilyl fatty acid derivatives compared with methyl ester derivatives. J Chromatogr A. 1999;862:199-208.
29. Lemaitre RN, King IB, Mozaffarian D, et al. Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the cardiovascular health study. Circulation. 2006;114:209-215.
30. Roberts TL, Wood DA, Riemersma RA, Gallagher PJ, Lampe FC. Trans isomers of oleic and linoleic acids in adipose tissue and sudden cardiac death. Lancet. 1995;345:278-282.
31. Harris WS, Reid KJ, Sands SA, Spertus JA. Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients. Am J Cardiol. 2007;99: 154-158.
32. Block RC, Harris WS, Reid KJ, Spertus JA. Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes? Am Heart J. 2008;156:1117-1123.
33. Baylin A, Kabagambe EK, Ascherio A, Spiegelman D, Campos H. High 18:2 trans-fatty acids in adipose tissue are associated with increased risk of nonfatal acute myocardial infarction in costa rican adults. J Nutr. 2003;133:1186-1191.
34. Sun Q, Ma J, Campos H, et al. A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation. 2007;115:1858-1865.
35. Oda E, Hatada K, Kimura J, Aizawa Y, Thanikachalam PV, Watanabe K. Relationships between serum unsaturated fatty acids and coronary risk factors: negative relations between nervonic acid and obesity-related risk factors. Int Heart J. 2005;46:975-985. (Pubitemid 43316742)
36. Glatz JF, Soffers AE, Katan MB. Fatty acid composition of serum cholesteryl esters and erythrocyte membranes as indicators of linoleic acid intake in man. Am J Clin Nutr. 1989;49:269-276.
37. Baylin A, Kabagambe EK, Siles X, Campos H. Adipose tissue biomarkers of fatty acid intake. Am J Clin Nutr. 2002;76:750-757.